MYND Life Sciences Inc. Stock OTC Markets
Equities
MYNDF
CA62857B1094
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0125 USD | -58.33% |
|
-49.80% | -59.94% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 717K |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -1M | EV / Sales 2022 | - |
Net Debt 2022 | 2.59 | Net Debt 2023 | 3 | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.05
x | P/E ratio 2023 |
-0.47
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20.47% |
1 day | -58.33% | ||
1 week | -49.80% | ||
Current month | -58.33% | ||
1 month | -49.80% | ||
3 months | -44.93% | ||
6 months | -58.33% | ||
Current year | -59.94% |
![Extreme 0.0125](/images/extremecours_fleche.png)
![Extreme 0.0125](/images/extremecours_fleche.png)
![Extreme 0.0125](/images/extremecours_fleche.png)
![Extreme 0.0125](/images/extremecours_fleche.png)
![Extreme 0.0125](/images/extremecours_fleche.png)
![Extreme 0.0125](/images/extremecours_fleche.png)
![Extreme 0.0125](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
John Campbell
CEO | Chief Executive Officer | 53 | 20-11-25 |
Lyle Oberg
FOU | Founder | 63 | 18-07-05 |
Founder | 65 | 18-07-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 65 | 18-07-05 | |
Lyle Oberg
FOU | Founder | 63 | 18-07-05 |
John Campbell
CEO | Chief Executive Officer | 53 | 20-11-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-01 | 0.0125 | -58.33% | 100 |
Delayed Quote OTC Markets, July 01, 2024 at 09:30 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+18.11% | 25.93B | |
-24.33% | 19.27B | |
-19.23% | 16.01B | |
-17.95% | 15.66B | |
-46.81% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- MYND Stock
- MYNDF Stock